Women who were in the second (OR = 0.262, 95% CI: 0.089-0.773) and third (OR = 0.118, 95% CI: 0.035-0.396) tertiles of serum obestatin had significantly lower risk of hypertriglyceridemia compared to the reference group (P trend < 0.001). Here, GHRL is linked to hypertriglyceridemia.